Paris, France ; Cambridge, Massachusetts (USA); November 15, 2022 – NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the “Company”) is a French biotechnology company in late-stage clinical development, pioneering physics-based approaches to expand treatment options for patients with Cancer, today announces that Laurent Levy, Co-Founder and Chairman of the Executive Board, and Bart Van Rhijn, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, December 1, 2022 at 3:15 p.m. CET / 9:15 a.m. ET during the Evercore ISI HealthCONx Conference.
The presentation will be streamed live on the Events page of the Investors section of the Company’s website. A replay will be available for 90 days after the event.